Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Infection Surveillance Solutions Market, by Product & Services
1.4.2 Europe Infection Surveillance Solutions Market, by End User
1.4.3 Europe Infection Surveillance Solutions Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. Europe Infection Surveillance Solutions Market by Product & Services
4.1 Europe Software Market by Country
4.2 Europe Infection Surveillance Solutions Market by Software Type
4.2.1 Europe On-premise Market by Country
4.2.2 Europe Web-based Software Market by Country
4.3 Europe Services Market by Country
Chapter 5. Europe Infection Surveillance Solutions Market by End User
5.1 Europe Hospitals Market by Country
5.2 Europe Long-term Care Facilities Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Infection Surveillance Solutions Market by Country
6.1 Germany Infection Surveillance Solutions Market
6.1.1 Germany Infection Surveillance Solutions Market by Product & Services
6.1.1.1 Germany Infection Surveillance Solutions Market by Software Type
6.1.2 Germany Infection Surveillance Solutions Market by End User
6.2 UK Infection Surveillance Solutions Market
6.2.1 UK Infection Surveillance Solutions Market by Product & Services
6.2.1.1 UK Infection Surveillance Solutions Market by Software Type
6.2.2 UK Infection Surveillance Solutions Market by End User
6.3 France Infection Surveillance Solutions Market
6.3.1 France Infection Surveillance Solutions Market by Product & Services
6.3.1.1 France Infection Surveillance Solutions Market by Software Type
6.3.2 France Infection Surveillance Solutions Market by End User
6.4 Russia Infection Surveillance Solutions Market
6.4.1 Russia Infection Surveillance Solutions Market by Product & Services
6.4.1.1 Russia Infection Surveillance Solutions Market by Software Type
6.4.2 Russia Infection Surveillance Solutions Market by End User
6.5 Spain Infection Surveillance Solutions Market
6.5.1 Spain Infection Surveillance Solutions Market by Product & Services
6.5.1.1 Spain Infection Surveillance Solutions Market by Software Type
6.5.2 Spain Infection Surveillance Solutions Market by End User
6.6 Italy Infection Surveillance Solutions Market
6.6.1 Italy Infection Surveillance Solutions Market by Product & Services
6.6.1.1 Italy Infection Surveillance Solutions Market by Software Type
6.6.2 Italy Infection Surveillance Solutions Market by End User
6.7 Rest of Europe Infection Surveillance Solutions Market
6.7.1 Rest of Europe Infection Surveillance Solutions Market by Product & Services
6.7.1.1 Rest of Europe Infection Surveillance Solutions Market by Software Type
6.7.2 Rest of Europe Infection Surveillance Solutions Market by End User
Chapter 7. Company Profiles
7.1 Becton, Dickinson and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.1.5.3 Product Launches and Product Expansions:
7.1.6 SWOT Analysis
7.2 Oracle Corporation (Cerner Corporation)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.6 SWOT Analysis
7.3 Wolters Kluwer N.V.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Product Launches and Product Expansions:
7.4 BioMérieux S.A.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.5 Baxter International, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Acquisition and Mergers:
7.6 Harris Healthcare (Constellation Software, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 Securitas AB
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.8 OSI Systems, Inc. (Spacelabs Healthcare)
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Gojo Industries, Inc.
7.9.1 Company Overview
7.10. Merative L.P. (Francisco Partners)
7.10.1 Company Overview
Unique Offerings 
